![Citeline Podcasts artwork](https://is1-ssl.mzstatic.com/image/thumb/Podcasts113/v4/0f/4f/ef/0f4fef8f-28fc-8de1-8d89-184cfda23e39/mza_5528053617673757912.jpg/100x100bb.jpg)
Zydus Lifesciences MD Sharvil Patel On Rare Disease Focus, New Corporate Identity, COVID Vaccine
Citeline Podcasts
English - April 21, 2022 04:06 - 26 minutes - 30 MB - ★★★★★ - 24 ratingsBusiness News Business News Homepage Download Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Zydus Lifesciences’ (formerly Cadila Healthcare) managing director Sharvil Patel speaks to Scrip on a host of topics ranging from a focus on rare diseases to a fresh corporate identity and plans for launch of a two-dose version of the world’s first plasmid DNA vaccine that it developed against COVID-19. Patel also talks about his personal business journey as well as the importance of building organizational agility to deal with uncertainty that companies are increasingly having to deal with.